Proper urinary elimination is a key indicator of your overall health, especially as you get older. If your ability to urinate is impaired, it can cause a wide variety of other conditions. Impaired ...
Dear Dr. Roach: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the diagnosis is “overactive ...
This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic regimens ...
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ...
Myrbetriq (mirabegron) is a brand-name drug that’s prescribed for overactive bladder in adults and certain children. It’s an extended-release medication. As with other drugs, Myrbetriq can cause side ...
The approval was based on data from the pivotal phase 3 EMPOWUR study. The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron; Urovant Sciences) for the treatment of overactive ...
Bladder stones (vesical calculi) almost always form due to an underlying issue like urinary stasis, obstruction, or foreign bodies. High-risk populations include women with pelvic organ prolapse and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback